Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 13/20 | 1.00 |
| ▸ | HSPA1A | P0DMV8 | 12/20 | 1.00 |
| ▸ | MASP2 | O00187 | 3/20 | 1.00 |
| ▸ | CDC25B | P30305 | 2/20 | 1.00 |
| ▸ | CD44 | P16070 | 2/20 | 1.00 |
| ▸ | MSN | P26038 | 2/20 | 1.00 |
| ▸ | EZH2 | Q15910 | 2/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 1/20 | 1.00 |
| ▸ | AKT1 | P31749 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 9/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.81 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.81 |
| ▸ | GAA | P10253 | 5/20 | 0.81 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.81 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.81 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.81 |
| ▸ | USP2 | O75604 | 2/20 | 0.81 |
| ▸ | NSD2 | O96028 | 2/20 | 0.81 |
| ▸ | ALPL | P05186 | 1/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29415450 | 1.00 | PTPN7 (1.00) | PTPN7HSPA1AMASP2CDC25BCD44 | |
| SCHEMBL16706084 | 0.90 | POLB (1.00) | PTPN7HSPA1AMASP2CDC25BCD44 | |
| SCHEMBL29954899 | 0.90 | POLB (1.00) | PTPN7HSPA1AMASP2CDC25BCD44 | |
| SCHEMBL17211738 | 0.90 | HSPA1A (0.81) | PTPN7HSPA1AMASP2CDC25BCD44 | |
| SCHEMBL16706087 | 0.84 | PTPN7 (1.00) | PTPN7HSPA1AMASP2CDC25BCD44 | |
| SCHEMBL3610631 | 0.84 | CDC25B (1.00) | PTPN7HSPA1AMASP2CDC25BCD44 | |
| SCHEMBL2116528 | 0.84 | PTPN7 (1.00) | PTPN7HSPA1AMASP2CDC25BCD44 | |
| SCHEMBL13186581 | 0.84 | PTPN7 (0.73) | PTPN7HSPA1AMASP2CDC25BCD44 | |
| SCHEMBL23949487 | 0.84 | KMT2A (1.00) | PTPN7HSPA1AMASP2CDC25BCD44 | |
| SCHEMBL2116204 | 0.84 | PTPN7 (0.85) | PTPN7HSPA1AMASP2CDC25BCD44 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| US-20230145071-A1 | MASP-2 INHIBITORS AND METHODS OF USE | OMEROS CORPORATION | 2023-05-11 | — | — | US | disclosed |
| US-20230145071-A1 | MASP-2 INHIBITORS AND METHODS OF USE | OMEROS CORPORATION | 2023-05-11 | — | — | US | disclosed |
| US-11584714-B2 | MASP-2 inhibitors and methods of use | OMEROS CORPORATION (US) | 2023-02-21 | — | — | US | disclosed |
| US-11559474-B2 | Hair lightening compositions and methods of use | L'OREAL (FR) | 2023-01-24 | — | — | US | disclosed |
| WO-2018119500-A1 | VISCOELASTIC COSMETIC COMPOSITIONS | L'OREAL (FR) | 2018-07-05 | — | — | WO | disclosed |
| EP-2931280-B1 | METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1 | PHUSIS THERAPEUTICS INC (US) | 2018-02-14 | — | — | EP | disclosed |
| US-9340532-B2 | Methods and compositions for inhibiting CNKSR1 | PHUSIS THERAPEUTICS, INC. (US) | 2016-05-17 | — | — | US | disclosed |
| US-20150307482-A1 | METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1 | PHUSIS THERAPEUTICS, INC. (US) | 2015-10-29 | — | — | US | disclosed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | disclosed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | disclosed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | disclosed |
| US-20090203726-A1 | SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS | MAXTHERA INC. (US) | 2009-08-13 | — | — | US | disclosed |
| US-20090203726-A1 | SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS | MAXTHERA INC. (US) | 2009-08-13 | — | — | US | disclosed |
| WO-2009073550-A2 | SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS | MAXTHERA, INC. (US) | 2009-06-11 | — | — | WO | disclosed |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | L'OREAL (FR) | 2009-01-29 | — | — | US | disclosed |
| US-20070072875-A1 | ANTI-INFLAMMATORY COMPOSITIONS AND METHODS OF USE | MCMASTER BRIAN | 2007-03-29 | — | — | US | disclosed |
| US-20070072875-A1 | ANTI-INFLAMMATORY COMPOSITIONS AND METHODS OF USE | MCMASTER BRIAN | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584714-B2 | MASP-2 inhibitors and methods of use | MASP2, METAP2, SPINT2 | PTPN7 1542/4885HSPA1A 3544/4885MASP2 1/4885 |
| US-20230145071-A1 | MASP-2 INHIBITORS AND METHODS OF USE | MASP2, METAP2, SPINT2 | PTPN7 1542/4885HSPA1A 3544/4885MASP2 1/4885 |
| US-20150307482-A1 | METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1 | CNKSR1, CAMKK1, CAMKK2 | PTPN7 1125/4885HSPA1A 4301/4885MASP2 3217/4885 |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | PTPN7 1180/4885HSPA1A 1414/4885MASP2 3934/4885 |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | CUTA, SYMPK, TPRKB | PTPN7 1673/4885HSPA1A 3324/4885MASP2 1612/4885 |
| US-20070072875-A1 | ANTI-INFLAMMATORY COMPOSITIONS AND METHODS OF USE | CCL11, CCL5, CCL2 | PTPN7 751/4885HSPA1A 895/4885MASP2 174/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | PTPN7 1432/4885HSPA1A 2508/4885MASP2 4350/4885 |
| US-20090203726-A1 | SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS | NISCH, NDUFS3, SDHA | PTPN7 3898/4885HSPA1A 581/4885MASP2 610/4885 |
| US-11559474-B2 | Hair lightening compositions and methods of use | TYR, ALAD, CYBA | PTPN7 1408/4885HSPA1A 3253/4885MASP2 4760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.